Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVast Res Share News (VAST)

Share Price Information for Vast Res (VAST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.22
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.02 (9.524%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.22
VAST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Hutchmed sinks on US FDA drug rejection

Tue, 03rd May 2022 11:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Vast Resources PLC, up 50% at 0.51 pence, 12-month range 0.08p-10.00p. The Romania and Zimbabwe-focused miner says revenue more than doubled to USD2.3 million in the first quarter from USD970,465 in the fourth quarter. Reports increase in tons milled and in dry-metric-ton production at the Baita Plai polymetallic mine in Romania.

----------

Eneraqua Technologies PLC, up 10% at 280.00p, up 1.1% from November listing price of 277.00p. The energy and water efficiency services provider wins contract from the Indian state government of Uttarakhand to reduce carbon emissions and improve water efficiency. The northern state has a population of over 10 million people. Contract is worth GBP900,000 from the state's Department of Horticulture will see Eneraqua supply systems to 340 horticultural farms across the state.

----------

AIM - LOSERS

----------

Hutchmed (China) Ltd, down 15% at 208.00p, 12-month range 202.50p-656.00p. The US Food & Drug Administration has rejected the drugmaker's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA said the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
27 Apr 2020 10:30

Vast Resources reports progress on Baita Plai

(Sharecast News) - Vast Resources updated the market on progress at its Baita Plai Polymetallic Mine in Romania on Monday, confirming that the first shipment of equipment has arrived in country, at the Port of Constanta.

Read more
16 Apr 2020 16:54

Vast Resources Raises GBP600,000 To Maintain Working Capital

Vast Resources Raises GBP600,000 To Maintain Working Capital

Read more
16 Apr 2020 15:28

Vast raises ?0.6m as it looks to complete Chiadzwa joint venture

(Sharecast News) - Mining company Vast Resources has raised ?0.6m before costs through a placing of 392,156,863 ordinary shares at a price of 0.153p each, it announced on Thursday.

Read more
16 Mar 2020 15:19

Vast Resources trying to maintain Baita Plai timeline

(Sharecast News) - Mining company Vast Resources updated the market on progress at its Baita Plai polymetallic mine in Romania on Monday, following President Iohannis declaring a state of emergency in the country as of 16 March, in response to the Covid-19 coronavirus pandemic.

Read more
31 Jan 2020 14:22

Vast Resources completes first drawdown of Atlas Capital facility

(Sharecast News) - Vast Resources announced on Friday that the first tranche drawdown process of the Atlas Capital Markets, adjoined with Atlas Special Opportunities, facility under the bond issue deed that it announced on 24 October, had been completed, with confirmation of payment now received.

Read more
2 Jan 2020 15:02

Vast Resources drawing down first tranche of Atlas Capital funding

(Sharecast News) - Mining company Vast Resources has submitted a drawdown request for the first tranche Issuance to Atlas Capital Markets, it announced on Thursday, in accordance with the terms and conditions of the bond issuance deed.

Read more
2 Jan 2020 12:16

Vast Resources Requests First Tranche Of Atlas Capital Funding

Vast Resources Requests First Tranche Of Atlas Capital Funding

Read more
31 Dec 2019 13:40

Vast Resources Receives GBP1,303 From Warrant Exercise

Vast Resources Receives GBP1,303 From Warrant Exercise

Read more
23 Dec 2019 17:35

Vast Resources Begins Drilling At Romania Polymetallic Project

Vast Resources Begins Drilling At Romania Polymetallic Project

Read more
23 Dec 2019 14:54

Vest Resources begins drilling at Baita Plai

(Sharecast News) - Vast Resources announced on Monday that it has started the drilling programme at its Baita Plai Polymetallic Mine in Romania.

Read more
18 Dec 2019 14:14

Vast Resources To Get First Part Of USD15 Million Facility By 2019-End

Vast Resources To Get First Part Of USD15 Million Facility By 2019-End

Read more
16 Dec 2019 16:22

Vast Resources announces cold commissioning of Baita Plai

(Sharecast News) - Mining company Vast Resources announced the cold commissioning of Baita Plai Polymetallic Mine on Monday.

Read more
28 Nov 2019 16:41

Botswana Diamonds And Vast Resources Agree Terms For New Zimbabwe Deal

Botswana Diamonds And Vast Resources Agree Terms For New Zimbabwe Deal

Read more
28 Nov 2019 16:05

Vast Resources revises agreement with Botswana Diamonds

(Sharecast News) - Romania and Zimbabwe-focussed mining company Vast Resources has revised its agreement with Botswana Diamonds as a consulting partner in the development of the Chiadzwa Community Diamond Concession in the Marange Diamond Fields of Zimbabwe, it announced on Thursday.

Read more
11 Nov 2019 12:05

Vast Resources Appoints Chief Financial Officer Fletcher To Board

Vast Resources Appoints Chief Financial Officer Fletcher To Board

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.